Breaking News Instant updates and real-time market news.

ALXN

Alexion

$112.03 /

-0.41 (-0.36%)

08:37
09/25/20
09/25
08:37
09/25/20
08:37

Alexion receives Japan MHLW approval for Ultomiris

Alexion announced that Japan's Ministry of Health, Labour and Welfare, or MHLW, approved Ultomiris for adults and children living with atypical hemolytic uremic syndrome, or aHUS. Ultomiris is the first and only long-acting C5 inhibitor for aHUS and is administered every other month for adults and children and monthly for children. Atypical HUS is an ultra-rare disease that can cause progressive injury to vital organs, primarily the kidneys, via damage to the walls of blood vessels and blood clots.

  • 06

    Oct

ALXN Alexion
$112.03 /

-0.41 (-0.36%)

08/31/20 Stifel
Alexion coverage transferred with a Hold rating at Stifel
08/24/20 SVB Leerink
SVB Leerink continues to view Alexion as good M&A fit for number of suitors
07/31/20 Truist
Alexion price target raised to $155 from $135 at SunTrust
07/30/20 William Blair
Alexion downgraded to Market Perform from Outperform at William Blair

TODAY'S FREE FLY STORIES

Hot Stocks
Splunk up 4% to $219.24 as analyst day meeting continues » 15:02
10/21/20
10/21
15:02
10/21/20
15:02
SPLK

Splunk

$211.70 /

-0.06 (-0.03%)

Splunk CFO said during…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPLK Splunk
$211.70 /

-0.06 (-0.03%)

SPLK Splunk
$211.70 /

-0.06 (-0.03%)

10/14/20
Fly Intel: Top five analyst downgrades
10/13/20 UBS
Splunk assumed with a Sell from Buy at UBS
10/02/20 Evercore ISI
Splunk upgraded to Outperform from In Line at Evercore ISI
09/25/20 Baird
Baird upgrades Splunk to Outperform on cloud momentum
SPLK Splunk
$211.70 /

-0.06 (-0.03%)

SPLK Splunk
$211.70 /

-0.06 (-0.03%)

SPLK Splunk
$211.70 /

-0.06 (-0.03%)

Conference/Events
Capstone Turbine to hold a conference call » 14:55
10/21/20
10/21
14:55
10/21/20
14:55
CPST

Capstone Turbine

$5.15 /

-0.35 (-6.36%)

Capstone's Senior…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPST Capstone Turbine
$5.15 /

-0.35 (-6.36%)

CPST Capstone Turbine
$5.15 /

-0.35 (-6.36%)

06/30/20 Maxim
Capstone Turbine downgraded to Hold from Buy at Maxim
11/11/19 Lake Street
Capstone Turbine price target lowered to $5 from $30 at Lake Street
11/08/19 Oppenheimer
Capstone Turbine downgraded to Perform from Outperform at Oppenheimer
11/08/19 Oppenheimer
Capstone Turbine downgraded to Perform from Outperform at Oppenheimer
CPST Capstone Turbine
$5.15 /

-0.35 (-6.36%)

Hot Stocks
Norfolk Southern, Trinity, others in JV to create tech platform for shipping » 14:49
10/21/20
10/21
14:49
10/21/20
14:49
NSC

Norfolk Southern

$213.64 /

-2.31 (-1.07%)

, TRN

Trinity Industries

$21.48 /

+0.135 (+0.63%)

, GATX

GATX

$69.05 /

-0.32 (-0.46%)

Norfolk Southern (NSC),…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NSC Norfolk Southern
$213.64 /

-2.31 (-1.07%)

TRN Trinity Industries
$21.48 /

+0.135 (+0.63%)

GATX GATX
$69.05 /

-0.32 (-0.46%)

NSC Norfolk Southern
$213.64 /

-2.31 (-1.07%)

10/16/20 Barclays
Norfolk Southern upgraded to Equal Weight with $230 target at Barclays
10/16/20 Barclays
Norfolk Southern upgraded to Equal Weight from Underweight at Barclays
10/08/20 Susquehanna
Norfolk Southern price target raised to $286 from $284 at Susquehanna
10/08/20 Citi
Norfolk Southern price target raised to $250 from $214 at Citi
TRN Trinity Industries
$21.48 /

+0.135 (+0.63%)

01/14/20 Wells Fargo
Trinity Industries downgraded to Underweight from Overweight at Wells Fargo
11/08/19 Susquehanna
Trinity Industries downgraded to Neutral from Positive at Susquehanna
GATX GATX
$69.05 /

-0.32 (-0.46%)

06/16/20 Stephens
GATX upgraded to Overweight as overcapacity looks set to end at Stephens
06/16/20 Stephens
GATX upgraded to Overweight from Equal Weight at Stephens
NSC Norfolk Southern
$213.64 /

-2.31 (-1.07%)

TRN Trinity Industries
$21.48 /

+0.135 (+0.63%)

GATX GATX
$69.05 /

-0.32 (-0.46%)

TRN Trinity Industries
$21.48 /

+0.135 (+0.63%)

NSC Norfolk Southern
$213.64 /

-2.31 (-1.07%)

Options
Tesla options imply 11.2% move in share price post-earnings » 14:49
10/21/20
10/21
14:49
10/21/20
14:49
TSLA

Tesla

$427.58 /

+5.61 (+1.33%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$427.58 /

+5.61 (+1.33%)

TSLA Tesla
$427.58 /

+5.61 (+1.33%)

10/19/20 Wedbush
Tesla price target raised to $500 from $475 at Wedbush
10/16/20 Morgan Stanley
Tesla price target raised to $333 from $272 at Morgan Stanley
10/14/20 Credit Suisse
Q3 beat could be positive catalyst for Tesla stock, says Credit Suisse
10/14/20 JPMorgan
NIO Inc. upgraded to Overweight from Neutral at JPMorgan
TSLA Tesla
$427.58 /

+5.61 (+1.33%)

  • 14
    Feb
TSLA Tesla
$427.58 /

+5.61 (+1.33%)

TSLA Tesla
$427.58 /

+5.61 (+1.33%)

TSLA Tesla
$427.58 /

+5.61 (+1.33%)

Recommendations
First CAR-T data for Crispr's CTX110 'not good,' says Raymond James » 14:46
10/21/20
10/21
14:46
10/21/20
14:46
CRSP

Crispr Therapeutics

$96.02 /

-10.91 (-10.20%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$96.02 /

-10.91 (-10.20%)

CRSP Crispr Therapeutics
$96.02 /

-10.91 (-10.20%)

14:40 Today Stifel
Crispr Therapeutics price target raised to $93 from $75 at Stifel
13:55 Today Roth Capital
Crispr Therapeutics price target raised to $115 from $105 at Roth Capital
12:22 Today William Blair
Crispr's CTX110 data 'encouraging' despite patient death, says William Blair
12:16 Today Piper Sandler
Crispr Therapeutics price target raised to $128 from $104 at Piper Sandler
CRSP Crispr Therapeutics
$96.02 /

-10.91 (-10.20%)

  • 01
    Jul
  • 21
    Nov
CRSP Crispr Therapeutics
$96.02 /

-10.91 (-10.20%)

Options
Digital Turbine call volume above normal and directionally bullish » 14:45
10/21/20
10/21
14:45
10/21/20
14:45
APPS

Digital Turbine

$35.04 /

-1.07 (-2.96%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APPS Digital Turbine
$35.04 /

-1.07 (-2.96%)

APPS Digital Turbine
$35.04 /

-1.07 (-2.96%)

06:55 Today Roth Capital
Digital Turbine price target raised to $40 from $25 at Roth Capital
10/01/20 B. Riley Securities
Digital Turbine price target raised to $40 from $23 at B. Riley Securities
08/06/20 Roth Capital
Digital Turbine price target raised to $25 from $13 at Roth Capital
08/06/20 Craig-Hallum
Digital Turbine price target raised to $24 from $15 at Craig-Hallum
APPS Digital Turbine
$35.04 /

-1.07 (-2.96%)

APPS Digital Turbine
$35.04 /

-1.07 (-2.96%)

APPS Digital Turbine
$35.04 /

-1.07 (-2.96%)

On The Fly
Fly Intel: What to watch in Coca-Cola earnings report » 14:44
10/21/20
10/21
14:44
10/21/20
14:44
KO

Coca-Cola

$50.13 /

-0.11 (-0.22%)

Coca-Cola (KO) is…

ShowHide Related Items >><<
KO Coca-Cola
$50.13 /

-0.11 (-0.22%)

KO Coca-Cola
$50.13 /

-0.11 (-0.22%)

10/20/20 Jefferies
National Beverage upgraded to Hold on better La Croix market share at Jefferies
10/12/20 Citi
PepsiCo upgraded to Buy from Neutral at Citi
09/28/20 Morgan Stanley
PepsiCo trading at good entry point ahead of earnings, says Morgan Stanley
09/03/20 Morgan Stanley
Brown-Forman price target raised to $66 from $56 at Morgan Stanley
KO Coca-Cola
$50.13 /

-0.11 (-0.22%)

KO Coca-Cola
$50.13 /

-0.11 (-0.22%)

KO Coca-Cola
$50.13 /

-0.11 (-0.22%)

KO Coca-Cola
$50.13 /

-0.11 (-0.22%)

Recommendations
Crispr Therapeutics price target raised to $93 from $75 at Stifel » 14:40
10/21/20
10/21
14:40
10/21/20
14:40
CRSP

Crispr Therapeutics

$96.16 /

-10.77 (-10.07%)

, ALLO

Allogene Therapeutics

$35.08 /

-0.69 (-1.93%)

, DTIL

Precision BioSciences

$6.53 /

+0.18 (+2.83%)

Stifel analyst Benjamin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$96.16 /

-10.77 (-10.07%)

ALLO Allogene Therapeutics
$35.08 /

-0.69 (-1.93%)

DTIL Precision BioSciences
$6.53 /

+0.18 (+2.83%)

CRSP Crispr Therapeutics
$96.16 /

-10.77 (-10.07%)

13:55 Today Roth Capital
Crispr Therapeutics price target raised to $115 from $105 at Roth Capital
12:22 Today William Blair
Crispr's CTX110 data 'encouraging' despite patient death, says William Blair
12:16 Today Piper Sandler
Crispr Therapeutics price target raised to $128 from $104 at Piper Sandler
10/05/20
Fly Intel: Top five analyst initiations
ALLO Allogene Therapeutics
$35.08 /

-0.69 (-1.93%)

10/15/20 Roth Capital
Allogene's new collaboration may enrich anticancer portfolio, says Roth Capital
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
06/08/20 SunTrust
Allogene Therapeutics price target raised to $50 from $32 at SunTrust
06/01/20
Fly Intel: Top five analyst downgrades
DTIL Precision BioSciences
$6.53 /

+0.18 (+2.83%)

07/27/20 BTIG
Precision BioSciences assumed with a Buy at BTIG
05/18/20 H.C. Wainwright
Precision BioSciences could have 'significant upside,' says H.C. Wainwright
04/02/20 Goldman Sachs
Precision BioSciences downgraded to Neutral from Buy at Goldman Sachs
04/02/20 Goldman Sachs
Precision BioSciences downgraded to Neutral from Buy at Goldman Sachs
CRSP Crispr Therapeutics
$96.16 /

-10.77 (-10.07%)

ALLO Allogene Therapeutics
$35.08 /

-0.69 (-1.93%)

DTIL Precision BioSciences
$6.53 /

+0.18 (+2.83%)

  • 01
    Jul
  • 02
    Jun
  • 21
    Nov
CRSP Crispr Therapeutics
$96.16 /

-10.77 (-10.07%)

ALLO Allogene Therapeutics
$35.08 /

-0.69 (-1.93%)

DTIL Precision BioSciences
$6.53 /

+0.18 (+2.83%)

Hot Stocks
Cruise, GM seek NHTSA approval for Origin deployment » 14:40
10/21/20
10/21
14:40
10/21/20
14:40
GM

General Motors

$35.68 /

+0.095 (+0.27%)

Self-driving car company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GM General Motors
$35.68 /

+0.095 (+0.27%)

GM General Motors
$35.68 /

+0.095 (+0.27%)

08:14 Today Morgan Stanley
Morgan Stanley highlights five reasons for General Motors' advance
10/20/20 Citi
Ford price target raised to $9 from $7.50 at Citi
10/20/20 Citi
General Motors price target raised to $57 from $54 at Citi
10/19/20 B. Riley Securities
Aspen Aerogels price target raised to $14 from $9 at B. Riley Securities
GM General Motors
$35.68 /

+0.095 (+0.27%)

GM General Motors
$35.68 /

+0.095 (+0.27%)

GM General Motors
$35.68 /

+0.095 (+0.27%)

GM General Motors
$35.68 /

+0.095 (+0.27%)

General news
Treasury Action: Treasuries have hardly budged all session » 14:30
10/21/20
10/21
14:30
10/21/20
14:30

Treasury Action:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Options
HSBC call volume above normal and directionally bullish » 14:25
10/21/20
10/21
14:25
10/21/20
14:25
HSBC

HSBC

$19.93 /

+0.03 (+0.15%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HSBC HSBC
$19.93 /

+0.03 (+0.15%)

HSBC HSBC
$19.93 /

+0.03 (+0.15%)

10/06/20 UBS
HSBC price target lowered to 310 GBp from 410 GBp at UBS
09/21/20 Wells Fargo
Money laundering headlines creating extra headline risk for banks, says Wells
08/11/20 Morgan Stanley
HSBC upgraded to Equal Weight from Underweight at Morgan Stanley
08/07/20 Berenberg
HSBC price target lowered to 380 GBp from 390 GBp at Berenberg
HSBC HSBC
$19.93 /

+0.03 (+0.15%)

HSBC HSBC
$19.93 /

+0.03 (+0.15%)

HSBC HSBC
$19.93 /

+0.03 (+0.15%)

HSBC HSBC
$19.93 /

+0.03 (+0.15%)

General news
Fed's Beige Book for the November 4, 5 FOMC meeting didn't contain any surprises » 14:20
10/21/20
10/21
14:20
10/21/20
14:20

Fed's Beige Book for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Technical Analysis
NASDAQ market internals summary » 14:17
10/21/20
10/21
14:17
10/21/20
14:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 14:16
10/21/20
10/21
14:16
10/21/20
14:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

General news
Prices rose modestly across Fed districts, Beige Book says » 14:09
10/21/20
10/21
14:09
10/21/20
14:09
SPX

S&P 500

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$343.75 /

+0.41 (+0.12%)

The Federal Reserve says…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$343.75 /

+0.41 (+0.12%)

SPX S&P 500
$0.00 /

+ (+0.00%)

09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
SPY SPDR S&P 500 ETF Trust
$343.75 /

+0.41 (+0.12%)

09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$343.75 /

+0.41 (+0.12%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$343.75 /

+0.41 (+0.12%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$343.75 /

+0.41 (+0.12%)

General news
Employment increased in almost all Fed districts, Beige Book says » 14:08
10/21/20
10/21
14:08
10/21/20
14:08
SPX

S&P 500

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$343.78 /

+0.44 (+0.13%)

The Federal Reserve says…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$343.78 /

+0.44 (+0.13%)

SPX S&P 500
$0.00 /

+ (+0.00%)

09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
SPY SPDR S&P 500 ETF Trust
$343.78 /

+0.44 (+0.13%)

09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$343.78 /

+0.44 (+0.13%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$343.78 /

+0.44 (+0.13%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$343.78 /

+0.44 (+0.13%)

General news
Economic activity increased across all Fe districts, Beige Book says » 14:07
10/21/20
10/21
14:07
10/21/20
14:07
SOX

PHLX Semiconductor Sector Index

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$343.78 /

+0.44 (+0.13%)

The Federal Reserve says…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$343.78 /

+0.44 (+0.13%)

SOX PHLX Semiconductor Sector Index
$0.00 /

+ (+0.00%)

10/19/20 Morgan Stanley
Microchip upgraded to Overweight at Morgan Stanley following underperformance
12/18/19 Morgan Stanley
Morgan Stanley upgrades Semiconductors sector view to In-Line
SPY SPDR S&P 500 ETF Trust
$343.78 /

+0.44 (+0.13%)

09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
SPY SPDR S&P 500 ETF Trust
$343.78 /

+0.44 (+0.13%)

SPY SPDR S&P 500 ETF Trust
$343.78 /

+0.44 (+0.13%)

SPY SPDR S&P 500 ETF Trust
$343.78 /

+0.44 (+0.13%)

Periodicals
Astra-Oxford COVID trial to continue in Brazil following patient death, Sky says » 14:06
10/21/20
10/21
14:06
10/21/20
14:06
AZN

AstraZeneca

$51.90 /

-0.28 (-0.54%)

After Brazil's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$51.90 /

-0.28 (-0.54%)

AZN AstraZeneca
$51.90 /

-0.28 (-0.54%)

10/08/20 JPMorgan
AstraZeneca FY20 guide could look conservative after Q3 results, says JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/29/20 Berenberg
AstraZeneca initiated with a Buy at Berenberg
09/28/20 Maxim
Maxim upgrades Inovio to Buy, says shares oversold after vaccine 'speed bump'
AZN AstraZeneca
$51.90 /

-0.28 (-0.54%)

AZN AstraZeneca
$51.90 /

-0.28 (-0.54%)

AZN AstraZeneca
$51.90 /

-0.28 (-0.54%)

AZN AstraZeneca
$51.90 /

-0.28 (-0.54%)

Options
Cronos Group call volume above normal and directionally bullish » 14:05
10/21/20
10/21
14:05
10/21/20
14:05
CRON

Cronos Group

$5.86 /

+0.18 (+3.17%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRON Cronos Group
$5.86 /

+0.18 (+3.17%)

CRON Cronos Group
$5.86 /

+0.18 (+3.17%)

09/09/20 Stifel
Cronos CEO transition 'natural part' of company's evolution, says Stifel
08/31/20 Roth Capital
Roth Capital believes MORE Act will not pass in 2020
06/24/20
Fly Intel: Top five analyst upgrades
06/24/20 Raymond James
Cronos Group upgraded to Outperform from Market Perform at Raymond James
CRON Cronos Group
$5.86 /

+0.18 (+3.17%)

CRON Cronos Group
$5.86 /

+0.18 (+3.17%)

CRON Cronos Group
$5.86 /

+0.18 (+3.17%)

CRON Cronos Group
$5.86 /

+0.18 (+3.17%)

Initiation
Bilibili initiated with a Buy at HSBC » 14:04
10/21/20
10/21
14:04
10/21/20
14:04
BILI

Bilibili

$44.97 /

-0.27 (-0.60%)

HSBC analyst Binnie Wong…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BILI Bilibili
$44.97 /

-0.27 (-0.60%)

BILI Bilibili
$44.97 /

-0.27 (-0.60%)

10/19/20 China Renaissance
Bilibili price target raised to $59 from $56 at China Renaissance
08/27/20
Fly Intel: Top five analyst downgrades
08/27/20 Nomura Instinet
Nomura Instinet downgrades Bilibili to Neutral, raises price target to $50
08/27/20 Nomura Instinet
Bilibili downgraded to Neutral from Buy at Nomura Instinet
BILI Bilibili
$44.97 /

-0.27 (-0.60%)

BILI Bilibili
$44.97 /

-0.27 (-0.60%)

BILI Bilibili
$44.97 /

-0.27 (-0.60%)

BILI Bilibili
$44.97 /

-0.27 (-0.60%)

Periodicals
Ant Group to $35B Shanghai offering after China watchdog approval, Reuters says » 14:01
10/21/20
10/21
14:01
10/21/20
14:01
BABA

Alibaba

$309.43 /

-0.89 (-0.29%)

China's Ant Group, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BABA Alibaba
$309.43 /

-0.89 (-0.29%)

BABA Alibaba
$309.43 /

-0.89 (-0.29%)

10/20/20 Barclays
Alibaba price target raised to $360 from $320 at Barclays
10/20/20 Oppenheimer
Oppenheimer starts Pinduoduo with Outperform, $100 price target
10/13/20 China Renaissance
Alibaba price target raised to $355 from $315 at China Renaissance
10/06/20 Goldman Sachs
Alibaba price target raised to $350 from $315 at Goldman Sachs
BABA Alibaba
$309.43 /

-0.89 (-0.29%)

BABA Alibaba
$309.43 /

-0.89 (-0.29%)

BABA Alibaba
$309.43 /

-0.89 (-0.29%)

BABA Alibaba
$309.43 /

-0.89 (-0.29%)

Recommendations
Crispr Therapeutics price target raised to $115 from $105 at Roth Capital » 13:55
10/21/20
10/21
13:55
10/21/20
13:55
CRSP

Crispr Therapeutics

$96.05 /

-10.88 (-10.17%)

Roth Capital analyst Tony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$96.05 /

-10.88 (-10.17%)

CRSP Crispr Therapeutics
$96.05 /

-10.88 (-10.17%)

12:22 Today William Blair
Crispr's CTX110 data 'encouraging' despite patient death, says William Blair
12:16 Today Piper Sandler
Crispr Therapeutics price target raised to $128 from $104 at Piper Sandler
10/05/20
Fly Intel: Top five analyst initiations
10/05/20 BofA
Crispr Therapeutics initiated with a Buy at BofA
CRSP Crispr Therapeutics
$96.05 /

-10.88 (-10.17%)

  • 01
    Jul
  • 21
    Nov
CRSP Crispr Therapeutics
$96.05 /

-10.88 (-10.17%)

Periodicals
AstraZeneca trial death not on Covid vaccine, Bloomberg reports » 13:47
10/21/20
10/21
13:47
10/21/20
13:47
AZN

AstraZeneca

$51.67 /

-0.51 (-0.98%)

The deceased AstraZeneca…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$51.67 /

-0.51 (-0.98%)

AZN AstraZeneca
$51.67 /

-0.51 (-0.98%)

10/08/20 JPMorgan
AstraZeneca FY20 guide could look conservative after Q3 results, says JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/29/20 Berenberg
AstraZeneca initiated with a Buy at Berenberg
09/28/20 Maxim
Maxim upgrades Inovio to Buy, says shares oversold after vaccine 'speed bump'
AZN AstraZeneca
$51.67 /

-0.51 (-0.98%)

AZN AstraZeneca
$51.67 /

-0.51 (-0.98%)

AZN AstraZeneca
$51.67 /

-0.51 (-0.98%)

AZN AstraZeneca
$51.67 /

-0.51 (-0.98%)

Options
Deutsche Bank call volume above normal and directionally bullish » 13:45
10/21/20
10/21
13:45
10/21/20
13:45
DB

Deutsche Bank

$9.42 /

-0.18 (-1.88%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DB Deutsche Bank
$9.42 /

-0.18 (-1.88%)

DB Deutsche Bank
$9.42 /

-0.18 (-1.88%)

10/19/20 Barclays
Deutsche Bank price target raised to EUR 5 from EUR 4.50 at Barclays
10/01/20 Societe Generale
Deutsche Bank upgraded to Hold from Sell at Societe Generale
09/21/20 Wells Fargo
Money laundering headlines creating extra headline risk for banks, says Wells
07/30/20 Morgan Stanley
Deutsche Bank price target raised to EUR 7.50 from EUR 7 at Morgan Stanley
DB Deutsche Bank
$9.42 /

-0.18 (-1.88%)

DB Deutsche Bank
$9.42 /

-0.18 (-1.88%)

DB Deutsche Bank
$9.42 /

-0.18 (-1.88%)

DB Deutsche Bank
$9.42 /

-0.18 (-1.88%)

General news
October Beige Book to be released at 14:00  13:45
10/21/20
10/21
13:45
10/21/20
13:45
 

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.